NCI Division of Cancer Prevention/LinkedIn
Dec 19, 2024, 02:16
Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research – NCI Division of Cancer Prevention
NCI Division of Cancer Prevention shared a post on LinkedIn:
“New Funding Opportunity!
Through this NOFO, NCI encourages applications that support the biochemical and genetic analyses of cancer risk, and the discovery and validation of early detection biomarkers. Selected applicants will use the unique biorepository resources of the NCI-sponsored Prostate, Lung, Colorectal, and Ovarian Cancer (PLCO) Screening Trial.”
More posts featuring NCI Division of Cancer Prevention.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Dec 19, 2024, 02:11
Dec 19, 2024, 01:58
Dec 19, 2024, 01:55
Dec 19, 2024, 01:47
Dec 18, 2024, 18:36
Dec 18, 2024, 18:34
Dec 18, 2024, 18:31